systems in rat retina as a function of age. Neurochem. Res.
17:599 – 604; 1992.
[18] Yamanaka, N.; Nishida, K.; Ota, K. Increase of superoxide dis- [32]
mutase activity in various human leukemia cells. Physiol. Chem.
Phys. 11:253–256; 1979.
[19] Anjaneyulu, K.; Anjaneyulu, R.; Sener, A.; Malaisse, W. J. The
stimulus-secretion coupling of glucose induced insulin release:
Thiol disulfide balance in pancratic islets. Biochemie 64:29 –36; [33]
1982.
[20] Ishii, H.; Jirousek, M. R.; Koya, D.; Takagi, C.; Xia, P.; Clermont,
A.; Bursell, S-E.; Kern, T. S.; Ballas, L. M.; Heath, W. F.;
Stramm, L. E.; Feener, E. P.; King, G. L. Amelioration of vascular
dysfunctions in diabetic rats by an oral PKC β inhibitor. Science [34]
272:728 –731; 1996.
[21] Bradford, M. M. A rapid and sensitive method for the quantitation
of microgram quantities of protein. Anal. Biochem. 72:248 –258;
1974.
[35]
[22] Makar, T.; Hungund, B.; Cook, G.; Kashfi, K.; Cooper, A. Lipid
metabolism and membrane composition are altered in the brains
of type II diabetic mice. J. Neurochem. 64:2159 –2168; 1995.
[23] Vannucci, S. J.; Gibbs, E. M.; Simpson, I. A. Glucose utilization
[36]
and glucose transporter proteins GLUT-1 and GLUT-3 in brains
of diabetic (db/db) mice. Am. J. Physiol. 272 (2 Pt. 1):E267–
E274; 1997.
[37]
[24] Gagne, J.; Milot, M.; Gelinas, S.; Lahsaini, A.; Trudeau, F.;
Martinoli, M. G.; Massicotte, G. Binding properties of glutamate
receptors in streptozotocin-induced diabetes in rats. Diabetes 46:
[38]
841– 846; 1997.
[25] Busiguina, S.; Chowen, J. A.; Argente, J.; Torres-Aleman, I.
Specific alterations of the insulin-like growth factor I sysytem in
the cerebellum of diabetic rats. Endocrinology 137:4980 – 4987;
[39]
1996.
[26] Ver, A.; Csermely, P.; Banyasz, T.; Kovacs, T.; Somogyi, J.
Alterations in the properties and isoform ratios of brain Na+/K+- ATPase in streptozotocin diabetic rats. Biochim. Bioph. Acta
[40]
1237:143–150; 1995.
[27] Janicki, P.; Horn, J-L.; Singh, G.; Janson, V.; Franks, W.; Franks,
J. Reduced anesthetic requirements, diminished brain plasma
membrane Ca2+-ATPase pumping, and enhanced brain synaptic [41]
plasma membrane phospholipid methylation in diabetic rats: ef- fects of insulin. Life Sci. 56:357–363; 1995.
[28] Cafe, C.; Torri, C.; Bertorelli, L.; Tartara, F.; Tancioni, F.; Gaetani, P.; Rodriguez, Y.; Baena, R.; Marzatico, F. Oxidative evnts in [42]
neuronal and glial cell-enriched fractions of rat cerebral cortex.
Free Radic. Biol. Med. 19:853– 857; 1995.
[29] Mooradian, A. The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 671:164 –169; [43]
1995.
[30] Kumagai, A. K.; Glasgow, B. J.; Pardridge, W. M. GLUT1
glucose transporter expression in the diabetic and nondiabetic
human eye. Invest Ophthal. Vis. Sci. 35:2887–2894; 1994. [44]
Kumagai, A. K.; Vinores, S. A.; Pardridge, W. M. Pathological
upregulation of inner blood-retinal barrier GLUT-1 glucose trans-
